Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Recombinant Protein Market Report 2016

  • QYR718388
  • 128 Pages
  • October 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Recombinant Protein

Revenue, means the sales value of Recombinant Protein

This report studies sales (consumption) of Recombinant Protein in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

Pfizer, Inc. (US)

Bayer HealthCare Pharmaceuticals, Inc. (US)

GlaxoSmithKline (UK)

AbbVie, Inc. (US)

Anavex Life Sciences Corp. (US)

Baxter International, Inc. (US)

Biocon (India)

Eli Lilly (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

Genentech (US)

Janssen Biotech, Inc. (US)

Kemwell Biopharma (India)

Novartis (Switzerland)

Sun Pharmaceutical Industries Ltd. (India)

Sanofi S.A. (France)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Recombinant Protein in these countries, from 2011 to 2021 (forecast), like

Germany

France

UK

Russia

Italy

Spain

Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on sales, market share and growth rate of Recombinant Protein in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Europe Recombinant Protein Market Report 2016

1 Recombinant Protein Overview

1.1 Product Overview and Scope of Recombinant Protein

1.2 Classification of Recombinant Protein

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Recombinant Protein

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Recombinant Protein Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Recombinant Protein (2011-2021)

1.5.1 Europe Recombinant Protein Sales and Growth Rate (2011-2021)

1.5.2 Europe Recombinant Protein Revenue and Growth Rate (2011-2021)

2 Europe Recombinant Protein by Manufacturers, Type and Application

2.1 Europe Recombinant Protein Market Competition by Manufacturers

2.1.1 Europe Recombinant Protein Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Recombinant Protein Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Recombinant Protein (Volume and Value) by Type

2.2.1 Europe Recombinant Protein Sales and Market Share by Type (2011-2016)

2.2.2 Europe Recombinant Protein Revenue and Market Share by Type (2011-2016)

2.3 Europe Recombinant Protein (Volume and Value) by Countries

2.3.1 Europe Recombinant Protein Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Recombinant Protein Revenue and Market Share by Countries (2011-2016)

2.4 Europe Recombinant Protein (Volume) by Application

3 Germany Recombinant Protein (Volume, Value and Sales Price)

3.1 Germany Recombinant Protein Sales and Value (2011-2016)

3.1.1 Germany Recombinant Protein Sales and Growth Rate (2011-2016)

3.1.2 Germany Recombinant Protein Revenue and Growth Rate (2011-2016)

3.1.3 Germany Recombinant Protein Sales Price Trend (2011-2016)

3.2 Germany Recombinant Protein Sales and Market Share by Manufacturers

3.3 Germany Recombinant Protein Sales and Market Share by Type

3.4 Germany Recombinant Protein Sales and Market Share by Application

4 France Recombinant Protein (Volume, Value and Sales Price)

4.1 France Recombinant Protein Sales and Value (2011-2016)

4.1.1 France Recombinant Protein Sales and Growth Rate (2011-2016)

4.1.2 France Recombinant Protein Revenue and Growth Rate (2011-2016)

4.1.4 France Recombinant Protein Sales Price Trend (2011-2016)

4.2 France Recombinant Protein Sales and Market Share by Manufacturers

4.3 France Recombinant Protein Sales and Market Share by Type

4.4 France Recombinant Protein Sales and Market Share by Application

5 UK Recombinant Protein (Volume, Value and Sales Price)

5.1 UK Recombinant Protein Sales and Value (2011-2016)

5.1.1 UK Recombinant Protein Sales and Growth Rate (2011-2016)

5.1.2 UK Recombinant Protein Revenue and Growth Rate (2011-2016)

5.1.5 UK Recombinant Protein Sales Price Trend (2011-2016)

5.2 UK Recombinant Protein Sales and Market Share by Manufacturers

5.3 UK Recombinant Protein Sales and Market Share by Type

5.4 UK Recombinant Protein Sales and Market Share by Application

6 Russia Recombinant Protein (Volume, Value and Sales Price)

6.1 Russia Recombinant Protein Sales and Value (2011-2016)

6.1.1 Russia Recombinant Protein Sales and Growth Rate (2011-2016)

6.1.2 Russia Recombinant Protein Revenue and Growth Rate (2011-2016)

6.1.6 Russia Recombinant Protein Sales Price Trend (2011-2016)

6.2 Russia Recombinant Protein Sales and Market Share by Manufacturers

6.3 Russia Recombinant Protein Sales and Market Share by Type

6.4 Russia Recombinant Protein Sales and Market Share by Application

7 Italy Recombinant Protein (Volume, Value and Sales Price)

7.1 Italy Recombinant Protein Sales and Value (2011-2016)

7.1.1 Italy Recombinant Protein Sales and Growth Rate (2011-2016)

7.1.2 Italy Recombinant Protein Revenue and Growth Rate (2011-2016)

7.1.7 Italy Recombinant Protein Sales Price Trend (2011-2016)

7.2 Italy Recombinant Protein Sales and Market Share by Manufacturers

7.3 Italy Recombinant Protein Sales and Market Share by Type

7.4 Italy Recombinant Protein Sales and Market Share by Application

8 Spain Recombinant Protein (Volume, Value and Sales Price)

8.1 Spain Recombinant Protein Sales and Value (2011-2016)

8.1.1 Spain Recombinant Protein Sales and Growth Rate (2011-2016)

8.1.2 Spain Recombinant Protein Revenue and Growth Rate (2011-2016)

8.1.8 Spain Recombinant Protein Sales Price Trend (2011-2016)

8.2 Spain Recombinant Protein Sales and Market Share by Manufacturers

8.3 Spain Recombinant Protein Sales and Market Share by Type

8.4 Spain Recombinant Protein Sales and Market Share by Application

9 Benelux Recombinant Protein (Volume, Value and Sales Price)

9.1 Benelux Recombinant Protein Sales and Value (2011-2016)

9.1.1 Benelux Recombinant Protein Sales and Growth Rate (2011-2016)

9.1.2 Benelux Recombinant Protein Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Recombinant Protein Sales Price Trend (2011-2016)

9.2 Benelux Recombinant Protein Sales and Market Share by Manufacturers

9.3 Benelux Recombinant Protein Sales and Market Share by Type

9.4 Benelux Recombinant Protein Sales and Market Share by Application

10 Europe Recombinant Protein Manufacturers Analysis

10.1 Pfizer, Inc. (US)

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Recombinant Protein Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 Pfizer, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Bayer HealthCare Pharmaceuticals, Inc. (US)

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Recombinant Protein Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 GlaxoSmithKline (UK)

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Recombinant Protein Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 GlaxoSmithKline (UK) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 AbbVie, Inc. (US)

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Recombinant Protein Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 AbbVie, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Anavex Life Sciences Corp. (US)

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Recombinant Protein Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Anavex Life Sciences Corp. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Baxter International, Inc. (US)

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Recombinant Protein Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Baxter International, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Biocon (India)

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Recombinant Protein Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 Biocon (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Eli Lilly (US)

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Recombinant Protein Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 Eli Lilly (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 F. Hoffmann-La Roche Ltd. (Switzerland)

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Recombinant Protein Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Genentech (US)

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Recombinant Protein Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 Genentech (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Janssen Biotech, Inc. (US)

10.12 Kemwell Biopharma (India)

10.13 Novartis (Switzerland)

10.14 Sun Pharmaceutical Industries Ltd. (India)

10.15 Sanofi S.A. (France)

11 Recombinant Protein Manufacturing Cost Analysis

11.1 Recombinant Protein Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Recombinant Protein

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Recombinant Protein Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Recombinant Protein Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Recombinant Protein Market Forecast (2016-2021)

14.1 Germany Recombinant Protein Sales Forecast (2016-2021)

14.2 France Recombinant Protein Sales Forecast (2016-2021)

14.3 UK Recombinant Protein Sales Forecast (2016-2021)

14.4 Russia Recombinant Protein Sales Forecast (2016-2021)

14.5 Italy Recombinant Protein Sales Forecast (2016-2021)

14.6 Spain Recombinant Protein Sales Forecast (2016-2021)

14.7 Benelux Recombinant Protein Sales Forecast (2016-2021)

14.8 Europe Recombinant Protein Sales Forecast by Type (2016-2021)

14.9 Europe Recombinant Protein Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Recombinant Protein

Table Classification of Recombinant Protein

Figure Europe Sales Market Share of Recombinant Protein by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Recombinant Protein

Figure Europe Sales Market Share of Recombinant Protein by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Recombinant Protein Revenue and Growth Rate (2011-2021)

Figure France Recombinant Protein Revenue and Growth Rate (2011-2021)

Figure UK Recombinant Protein Revenue and Growth Rate (2011-2021)

Figure Russia Recombinant Protein Revenue and Growth Rate (2011-2021)

Figure Italy Recombinant Protein Revenue and Growth Rate (2011-2021)

Figure Spain Recombinant Protein Revenue and Growth Rate (2011-2021)

Figure Benelux Recombinant Protein Revenue and Growth Rate (2011-2021)

Figure Europe Recombinant Protein Sales and Growth Rate (2011-2021)

Figure Europe Recombinant Protein Revenue and Growth Rate (2011-2021)

Table Europe Recombinant Protein Sales of Key Manufacturers (2015 and 2016)

Table Europe Recombinant Protein Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Recombinant Protein Sales Share by Manufacturers

Figure 2016 Recombinant Protein Sales Share by Manufacturers

Table Europe Recombinant Protein Revenue by Manufacturers (2015 and 2016)

Table Europe Recombinant Protein Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Recombinant Protein Revenue Share by Manufacturers

Table 2016 Europe Recombinant Protein Revenue Share by Manufacturers

Table Europe Recombinant Protein Sales and Market Share by Type (2011-2016)

Table Europe Recombinant Protein Sales Share by Type (2011-2016)

Figure Sales Market Share of Recombinant Protein by Type (2011-2016)

Figure Europe Recombinant Protein Sales Growth Rate by Type (2011-2016)

Table Europe Recombinant Protein Revenue and Market Share by Type (2011-2016)

Table Europe Recombinant Protein Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Recombinant Protein by Type (2011-2016)

Figure Europe Recombinant Protein Revenue Growth Rate by Type (2011-2016)

Table Europe Recombinant Protein Sales and Market Share by Countries (2011-2016)

Table Europe Recombinant Protein Sales Share by Countries (2011-2016)

Figure Sales Market Share of Recombinant Protein by Countries (2011-2016)

Table Europe Recombinant Protein Revenue and Market Share by Countries (2011-2016)

Table Europe Recombinant Protein Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Recombinant Protein by Countries (2011-2016)

Table Europe Recombinant Protein Sales and Market Share by Application (2011-2016)

Table Europe Recombinant Protein Sales Share by Application (2011-2016)

Figure Sales Market Share of Recombinant Protein by Application (2011-2016)

Figure Germany Recombinant Protein Sales and Growth Rate (2011-2016)

Figure Germany Recombinant Protein Revenue and Growth Rate (2011-2016)

Figure Germany Recombinant Protein Sales Price Trend (2011-2016)

Table Germany Recombinant Protein Sales by Manufacturers (2015 and 2016)

Table Germany Recombinant Protein Market Share by Manufacturers (2015 and 2016)

Table Germany Recombinant Protein Sales by Type (2015 and 2016)

Table Germany Recombinant Protein Market Share by Type (2015 and 2016)

Table Germany Recombinant Protein Sales by Application (2015 and 2016)

Table Germany Recombinant Protein Market Share by Application (2015 and 2016)

Figure France Recombinant Protein Sales and Growth Rate (2011-2016)

Figure France Recombinant Protein Revenue and Growth Rate (2011-2016)

Figure France Recombinant Protein Sales Price Trend (2011-2016)

Table France Recombinant Protein Sales by Manufacturers (2015 and 2016)

Table France Recombinant Protein Market Share by Manufacturers (2015 and 2016)

Table France Recombinant Protein Sales by Type (2015 and 2016)

Table France Recombinant Protein Market Share by Type (2015 and 2016)

Table France Recombinant Protein Sales by Application (2015 and 2016)

Table France Recombinant Protein Market Share by Application (2015 and 2016)

Figure UK Recombinant Protein Sales and Growth Rate (2011-2016)

Figure UK Recombinant Protein Revenue and Growth Rate (2011-2016)

Figure UK Recombinant Protein Sales Price Trend (2011-2016)

Table UK Recombinant Protein Sales by Manufacturers (2015 and 2016)

Table UK Recombinant Protein Market Share by Manufacturers (2015 and 2016)

Table UK Recombinant Protein Sales by Type (2015 and 2016)

Table UK Recombinant Protein Market Share by Type (2015 and 2016)

Table UK Recombinant Protein Sales by Application (2015 and 2016)

Table UK Recombinant Protein Market Share by Application (2015 and 2016)

Figure Russia Recombinant Protein Sales and Growth Rate (2011-2016)

Figure Russia Recombinant Protein Revenue and Growth Rate (2011-2016)

Figure Russia Recombinant Protein Sales Price Trend (2011-2016)

Table Russia Recombinant Protein Sales by Manufacturers (2015 and 2016)

Table Russia Recombinant Protein Market Share by Manufacturers (2015 and 2016)

Table Russia Recombinant Protein Sales by Type (2015 and 2016)

Table Russia Recombinant Protein Market Share by Type (2015 and 2016)

Table Russia Recombinant Protein Sales by Application (2015 and 2016)

Table Russia Recombinant Protein Market Share by Application (2015 and 2016)

Figure Italy Recombinant Protein Sales and Growth Rate (2011-2016)

Figure Italy Recombinant Protein Revenue and Growth Rate (2011-2016)

Figure Italy Recombinant Protein Sales Price Trend (2011-2016)

Table Italy Recombinant Protein Sales by Manufacturers (2015 and 2016)

Table Italy Recombinant Protein Market Share by Manufacturers (2015 and 2016)

Table Italy Recombinant Protein Sales by Type (2015 and 2016)

Table Italy Recombinant Protein Market Share by Type (2015 and 2016)

Table Italy Recombinant Protein Sales by Application (2015 and 2016)

Table Italy Recombinant Protein Market Share by Application (2015 and 2016)

Figure Spain Recombinant Protein Sales and Growth Rate (2011-2016)

Figure Spain Recombinant Protein Revenue and Growth Rate (2011-2016)

Figure Spain Recombinant Protein Sales Price Trend (2011-2016)

Table Spain Recombinant Protein Sales by Manufacturers (2015 and 2016)

Table Spain Recombinant Protein Market Share by Manufacturers (2015 and 2016)

Table Spain Recombinant Protein Sales by Type (2015 and 2016)

Table Spain Recombinant Protein Market Share by Type (2015 and 2016)

Table Spain Recombinant Protein Sales by Application (2015 and 2016)

Table Spain Recombinant Protein Market Share by Application (2015 and 2016)

Figure Benelux Recombinant Protein Sales and Growth Rate (2011-2016)

Figure Benelux Recombinant Protein Revenue and Growth Rate (2011-2016)

Figure Benelux Recombinant Protein Sales Price Trend (2011-2016)

Table Benelux Recombinant Protein Sales by Manufacturers (2015 and 2016)

Table Benelux Recombinant Protein Market Share by Manufacturers (2015 and 2016)

Table Benelux Recombinant Protein Sales by Type (2015 and 2016)

Table Benelux Recombinant Protein Market Share by Type (2015 and 2016)

Table Benelux Recombinant Protein Sales by Application (2015 and 2016)

Table Benelux Recombinant Protein Market Share by Application (2015 and 2016)

Table Recombinant Protein Basic Information List

Table Pfizer, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (US) Basic Information List

Table Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer HealthCare Pharmaceuticals, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)

Table GlaxoSmithKline (UK) Basic Information List

Table GlaxoSmithKline (UK) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline (UK) Recombinant Protein Sales Market Share (2011-2016)

Table AbbVie, Inc. (US) Basic Information List

Table AbbVie, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbbVie, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)

Table Anavex Life Sciences Corp. (US) Basic Information List

Table Anavex Life Sciences Corp. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Anavex Life Sciences Corp. (US) Recombinant Protein Sales Market Share (2011-2016)

Table Baxter International, Inc. (US) Basic Information List

Table Baxter International, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Baxter International, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)

Table Biocon (India) Basic Information List

Table Biocon (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon (India) Recombinant Protein Sales Market Share (2011-2016)

Table Eli Lilly (US) Basic Information List

Table Eli Lilly (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly (US) Recombinant Protein Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Recombinant Protein Sales Market Share (2011-2016)

Table Genentech (US) Basic Information List

Table Genentech (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech (US) Recombinant Protein Sales Market Share (2011-2016)

Table Janssen Biotech, Inc. (US) Basic Information List

Table Janssen Biotech, Inc. (US) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Janssen Biotech, Inc. (US) Recombinant Protein Sales Market Share (2011-2016)

Table Kemwell Biopharma (India) Basic Information List

Table Kemwell Biopharma (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kemwell Biopharma (India) Recombinant Protein Sales Market Share (2011-2016)

Table Novartis (Switzerland) Basic Information List

Table Novartis (Switzerland) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis (Switzerland) Recombinant Protein Sales Market Share (2011-2016)

Table Sun Pharmaceutical Industries Ltd. (India) Basic Information List

Table Sun Pharmaceutical Industries Ltd. (India) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sun Pharmaceutical Industries Ltd. (India) Recombinant Protein Sales Market Share (2011-2016)

Table Sanofi S.A. (France) Basic Information List

Table Sanofi S.A. (France) Recombinant Protein Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi S.A. (France) Recombinant Protein Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Recombinant Protein

Figure Manufacturing Process Analysis of Recombinant Protein

Figure Recombinant Protein Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Protein Major Manufacturers in 2015

Table Major Buyers of Recombinant Protein

Table Distributors/Traders List

Figure Germany Recombinant Protein Sales and Growth Rate Forecast (2016-2021)

Figure Germany Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)

Figure France Recombinant Protein Sales and Growth Rate Forecast (2016-2021)

Figure France Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)

Figure UK Recombinant Protein Sales and Growth Rate Forecast (2016-2021)

Figure UK Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Recombinant Protein Sales and Growth Rate Forecast (2016-2021)

Figure Russia Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Recombinant Protein Sales and Growth Rate Forecast (2016-2021)

Figure Italy Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Recombinant Protein Sales and Growth Rate Forecast (2016-2021)

Figure Spain Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Recombinant Protein Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Recombinant Protein Revenue and Growth Rate Forecast (2016-2021)

Table Europe Recombinant Protein Sales Forecast by Type (2016-2021)

Table Europe Recombinant Protein Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370